{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:33:43Z","timestamp":1783110823131,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06553-1","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T01:42:37Z","timestamp":1765158157000},"page":"6439-6445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of PR2-based immunotherapy in the treatment of diffuse large B-cell lymphoma-associated neurolymphomatosis: A report on two cases"],"prefix":"10.1007","volume":"104","author":[{"given":"Xiangmin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"Pt 8","key":"6553_CR1","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/brain\/awt193","volume":"136","author":"M Tomita","year":"2013","unstructured":"Tomita M, Koike H, Kawagashira Y, Iijima M, Adachi H, Taguchi J, Abe T, Sako K, Tsuji Y, Nakagawa M, Kanda F, Takeda F, Sugawara M, Toyoshima I, Asano N, Sobue G (2013) Clinicopathological features of neuropathy associated with lymphoma. Brain 136(Pt 8):2563\u20132578. https:\/\/doi.org\/10.1093\/brain\/awt193","journal-title":"Brain"},{"issue":"1","key":"6553_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s44276-024-00053-x","volume":"2","author":"E Xu","year":"2024","unstructured":"Xu E, Ho Q, Liu A, Gautam S, Wong ET (2024) The natural history of neurolymphomatosis. BJC Rep 2(1):34. https:\/\/doi.org\/10.1038\/s44276-024-00053-x","journal-title":"BJC Rep"},{"issue":"4","key":"6553_CR3","doi-asserted-by":"publisher","first-page":"e209698","DOI":"10.1212\/wnl.0000000000209698","volume":"103","author":"LD Kaulen","year":"2024","unstructured":"Kaulen LD, Hielscher T, Doubrovinskaia S, Hoffmann DC, Kessler T, Traub BL, Baehring JM, Wick W (2024) Clinical presentation, management, and outcome in neurolymphomatosis: a systematic review. Neurology 103(4):e209698. https:\/\/doi.org\/10.1212\/wnl.0000000000209698","journal-title":"Neurology"},{"issue":"2","key":"6553_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/neuonc\/nop021","volume":"12","author":"HK Gan","year":"2010","unstructured":"Gan HK, Azad A, Cher L, Mitchell PL (2010) Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neurooncol 12(2):212\u2013215. https:\/\/doi.org\/10.1093\/neuonc\/nop021","journal-title":"Neurooncol"},{"issue":"24","key":"6553_CR5","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","volume":"115","author":"S Grisariu","year":"2010","unstructured":"Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T (2010) Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood 115(24):5005\u20135011. https:\/\/doi.org\/10.1182\/blood-2009-12-258210","journal-title":"Blood"},{"issue":"2","key":"6553_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/neuonc\/nop021","volume":"5","author":"JM Baehring","year":"2003","unstructured":"Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH (2003) Neurolymphomatosis. Neurooncology 5(2):104\u2013115. https:\/\/doi.org\/10.1093\/neuonc\/nop021","journal-title":"Neurooncology"},{"issue":"4","key":"6553_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/nop\/npv025","volume":"2","author":"W Grisold","year":"2015","unstructured":"Grisold W, Grisold A, Marosi C, Meng S, Briani C (2015) Neuropathies associated with lymphoma(\u2020). Neuro-oncol Pract 2(4):167\u2013178. https:\/\/doi.org\/10.1093\/nop\/npv025","journal-title":"Neuro-oncol Pract"},{"issue":"1","key":"6553_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1754-9485.12321","volume":"60","author":"AT Lim","year":"2016","unstructured":"Lim AT, Clucas D, Khoo C, Parameswaran BK, Lau E (2016) Neurolymphomatosis: MRI and (18) FDG-PET features. J Med Imaging Radiat Oncol 60(1):92\u201395. https:\/\/doi.org\/10.1111\/1754-9485.12321","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"7","key":"6553_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00256-019-3145-3","volume":"48","author":"AH DeVries","year":"2019","unstructured":"DeVries AH, Howe BM, Spinner RJ, Broski SM (2019) B-cell peripheral neurolymphomatosis: MRI and (18)F-FDG PET\/CT imaging characteristics. Skeletal Radiol 48(7):1043\u20131050. https:\/\/doi.org\/10.1007\/s00256-019-3145-3","journal-title":"Skeletal Radiol"},{"issue":"22","key":"6553_CR10","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/jco.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE, Batchelor TT, Ferreri AJ, Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A, Soussain C, DeAngelis LM, Neuwelt EA, O\u2019Neill BP, Thiel E, Shenkier T, Graus F, van den Bent M, Seymour JF, Poortmans P, Armitage JO, Cavalli F (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23(22):5034\u20135043. https:\/\/doi.org\/10.1200\/jco.2005.13.524","journal-title":"J Clin Oncol"},{"issue":"27","key":"6553_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncology: Official J Am Soc Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/jco.2013.54.8800","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"6553_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11060-004-3389-0","volume":"72","author":"F Bokstein","year":"2005","unstructured":"Bokstein F, Goor O, Shihman B, Rochkind S, Even-Sapir E, Metser U, Neufeld M (2005) Assessment of neurolymphomatosis by brachial plexus biopsy and PET\/CT. Report of a case. J Neurooncol 72(2):163\u2013167. https:\/\/doi.org\/10.1007\/s11060-004-3389-0","journal-title":"J Neurooncol"},{"issue":"1","key":"6553_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0609.2004.00369.x","volume":"74","author":"P Kanter","year":"2005","unstructured":"Kanter P, Zeidman A, Streifler J, Marmelstein V, Even-Sapir E, Metser U, Stein GY, Cohen AM (2005) PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol 74(1):66\u201369. https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00369.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"6553_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11060-006-9164-7","volume":"80","author":"JH Kim","year":"2006","unstructured":"Kim JH, Jang JH, Koh SB (2006) A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 80(2):209\u2013210. https:\/\/doi.org\/10.1007\/s11060-006-9164-7","journal-title":"J Neurooncol"},{"issue":"24","key":"6553_CR15","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1182\/blood-2013-08-460311","volume":"122","author":"CG Mullighan","year":"2013","unstructured":"Mullighan CG (2013) Genome sequencing of lymphoid malignancies. Blood 122(24):3899\u20133907. https:\/\/doi.org\/10.1182\/blood-2013-08-460311","journal-title":"Blood"},{"issue":"9","key":"6553_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43(9):830\u2013837. https:\/\/doi.org\/10.1038\/ng.892","journal-title":"Nat Genet"},{"issue":"14","key":"6553_CR17","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/jco.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncology: Official J Am Soc Clin Oncol 29(14):1844\u20131854. https:\/\/doi.org\/10.1200\/jco.2010.32.5225","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"1","key":"6553_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2020202835","volume":"298","author":"N Soni","year":"2021","unstructured":"Soni N, Ora M (2021) FDG PET\/CT in neurolymphomatosis. Radiology 298(1):36. https:\/\/doi.org\/10.1148\/radiol.2020202835","journal-title":"Radiology"},{"issue":"1\u20132","key":"6553_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2014.04.030","volume":"342","author":"S Lagarde","year":"2014","unstructured":"Lagarde S, Tabouret E, Matta M, Franques J, Attarian S, Pouget J, De Maues A, Figarella-Branger D, Dory-Lautrec P, Chinot O, Barri\u00e9 M (2014) Primary neurolymphomatosis diagnosis and treatment: a retrospective study. J Neurol Sci 342(1\u20132):178\u2013181. https:\/\/doi.org\/10.1016\/j.jns.2014.04.030","journal-title":"J Neurol Sci"},{"issue":"3","key":"6553_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3988\/jcn.2016.12.3.274","volume":"12","author":"R Shree","year":"2016","unstructured":"Shree R, Goyal MK, Modi M, Gaspar BL, Radotra BD, Ahuja CK, Mittal BR, Prakash G (2016) The diagnostic dilemma of neurolymphomatosis. J Clin Neurol (Seoul Korea) 12(3):274\u2013281. https:\/\/doi.org\/10.3988\/jcn.2016.12.3.274","journal-title":"J Clin Neurol (Seoul Korea)"},{"issue":"12","key":"6553_CR21","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.bbmt.2020.08.012","volume":"26","author":"A Khurana","year":"2020","unstructured":"Khurana A, Micallef IN, LaPlant BR, Patrick O, Neill B, Habermann TM, Ansell SM, Inwards DJ, Porrata LF, Paludo J, Bisneto JCV, Johnston PB (2020) Outcomes of autologous stem cell transplant consolidation in primary central nervous system lymphoma: A Mayo clinic experience. Biol Blood Marrow Transp 26(12):2217\u20132222. https:\/\/doi.org\/10.1016\/j.bbmt.2020.08.012","journal-title":"Biol Blood Marrow Transp"},{"issue":"3","key":"6553_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00415-020-10202-0","volume":"268","author":"J Jeong","year":"2021","unstructured":"Jeong J, Kim SW, Sung DH (2021) Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes. J Neurol 268(3):851\u2013859. https:\/\/doi.org\/10.1007\/s00415-020-10202-0","journal-title":"J Neurol"},{"issue":"20","key":"6553_CR23","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1158\/0008-5472.Can-21-2926","volume":"81","author":"MR Pitter","year":"2021","unstructured":"Pitter MR, Zou W (2021) Uncovering the immunoregulatory function and therapeutic potential of the PD-1\/PD-L1 axis in cancer. Cancer Res 81(20):5141\u20135143. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-2926","journal-title":"Cancer Res"},{"issue":"12","key":"6553_CR24","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/leu.2014.137","volume":"28","author":"D Rossille","year":"2014","unstructured":"Rossille D, Gressier M, Damotte D, Maucort-Boulch D, Pangault C, Semana G, Le Gouill S, Haioun C, Tarte K, Lamy T, Milpied N, Fest T (2014) High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-cell lymphoma: results from a French multicenter clinical trial. Leukemia 28(12):2367\u20132375. https:\/\/doi.org\/10.1038\/leu.2014.137","journal-title":"Leukemia"},{"key":"6553_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00054","volume":"10","author":"P David","year":"2019","unstructured":"David P, Megger DA, Kaiser T, Werner T, Liu J, Chen L, Sitek B, Dittmer U, Zelinskyy G (2019) The PD-1\/PD-L1 pathway affects the expansion and function of cytotoxic CD8(+) T cells during an acute retroviral infection. Front Immunol 10:54. https:\/\/doi.org\/10.3389\/fimmu.2019.00054","journal-title":"Front Immunol"},{"issue":"20","key":"6553_CR26","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1158\/1078-0432.Ccr-15-0200","volume":"21","author":"G G\u00f6rg\u00fcn","year":"2015","unstructured":"G\u00f6rg\u00fcn G, Samur MK, Cowens KB, Paula S, Bianchi G, Anderson JE, White RE, Singh A, Ohguchi H, Suzuki R, Kikuchi S, Harada T, Hideshima T, Tai YT, Laubach JP, Raje N, Magrangeas F, Minvielle S, Avet-Loiseau H, Munshi NC, Dorfman DM, Richardson PG, Anderson KC (2015) Lenalidomide enhances immune checkpoint blockade-induced immune response in multiple myeloma. Clin Cancer Research: Official J Am Association Cancer Res 21(20):4607\u20134618. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0200","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"6553_CR27","doi-asserted-by":"publisher","unstructured":"Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodr\u00edguez JL, Vicente Baz D, Codes Manuel de Villena M, Provencio M (2010) Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. Journal of biomedicine & biotechnology 2010. https:\/\/doi.org\/10.1155\/2010\/846872","DOI":"10.1155\/2010\/846872"},{"issue":"4","key":"6553_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235\u2013242. https:\/\/doi.org\/10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"issue":"5","key":"6553_CR29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/bloodadvances.2020003666","volume":"5","author":"A Khurana","year":"2021","unstructured":"Khurana A, Novo M, Nowakowski GS, Ristow KM, Spinner RJ, Hunt CH, King RL, Lachance DH, Habermann TM, Micallef IN, Johnston PB (2021) Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. Blood Adv 5(5):1379\u20131387. https:\/\/doi.org\/10.1182\/bloodadvances.2020003666","journal-title":"Blood Adv"},{"issue":"22","key":"6553_CR30","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1182\/blood.2018889931","volume":"133","author":"M Pascual","year":"2019","unstructured":"Pascual M, Mena-Varas M, Robles EF, Garcia-Barchino MJ, Panizo C, Hervas-Stubbs S, Alignani D, Sagardoy A, Martinez-Ferrandis JI, Bunting KL, Meier S, Sagaert X, Bagnara D, Guruceaga E, Blanco O, Celay J, Mart\u00ednez-Baztan A, Casares N, Lasarte JJ, MacCarthy T, Melnick A, Martinez-Climent JA, Roa S (2019) PD-1\/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. Blood 133(22):2401\u20132412. https:\/\/doi.org\/10.1182\/blood.2018889931","journal-title":"Blood"},{"key":"6553_CR31","doi-asserted-by":"publisher","unstructured":"Yang Y, Shaffer AL 3rd, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, Young RM, Zhao H, Yang Y, Xu W, Buggy JJ, Balasubramanian S, Mathews LA, Shinn P, Guha R, Ferrer M, Thomas C, Waldmann TA, Staudt LM (2012) Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell 21(6):723\u2013737. https:\/\/doi.org\/10.1016\/j.ccr.2012.05.024","DOI":"10.1016\/j.ccr.2012.05.024"},{"issue":"12","key":"6553_CR32","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","volume":"39","author":"WH Wilson","year":"2021","unstructured":"Wilson WH, Wright GW, Huang DW, Hodkinson B, Balasubramanian S, Fan Y, Vermeulen J, Shreeve M, Staudt LM (2021) Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. Cancer Cell 39(12):1643\u20131653e1643. https:\/\/doi.org\/10.1016\/j.ccell.2021.10.006","journal-title":"Cancer Cell"},{"issue":"21","key":"6553_CR33","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/jco.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM (2017) Primary CNS lymphoma. J Clin Oncology: Official J Am Soc Clin Oncol 35(21):2410\u20132418. https:\/\/doi.org\/10.1200\/jco.2017.72.7602","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"12","key":"6553_CR34","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/ajh.27505","volume":"99","author":"LD Kaulen","year":"2024","unstructured":"Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, Choi BD, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J (2024) Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. Am J Hematol 99(12):2411\u20132415. https:\/\/doi.org\/10.1002\/ajh.27505","journal-title":"Am J Hematol"},{"issue":"8","key":"6553_CR35","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1002\/ajh.26233","volume":"96","author":"A Khurana","year":"2021","unstructured":"Khurana A, Dalland JC, Young JR, Inwards DJ, Paludo J (2021) Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis. Am J Hematol 96(8):E298\u2013e301. https:\/\/doi.org\/10.1002\/ajh.26233","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06553-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:17Z","timestamp":1767485717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6553"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06553-1","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the pa- tient for the publication of any potentially identifable data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}